3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3174B |
Nitrate/Nitrite (Qualitative), Blood (Forensic) |
3174SP |
Nitrate/Nitrite (Qualitative), Serum/Plasma |
3216B |
Nordiazepam and Metabolite, Blood |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3216U |
Nordiazepam and Metabolite, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3250SP |
Oxalate, Serum/Plasma |
3260B |
Oxazepam, Blood |
3260SP |
Oxazepam, Serum/Plasma |
3260U |
Oxazepam, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3532B |
Phencyclidine Screen, Blood |
3532FL |
Phencyclidine Screen, Fluid |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |